Factors that influence rheumatologists’ anti-tumor necrosis factor alpha prescribing decisions: a qualitative study
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2520-1026
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Factors that influence rheumatologists’ anti-tumor necrosis factor alpha prescribing decisions: a qualitative study ; volume:3 ; number:1 ; day:19 ; month:12 ; year:2019 ; pages:1-12 ; date:12.2019
BMC Rheumatology ; 3, Heft 1 (19.12.2019), 1-12, 12.2019
- Creator
-
Gavan, Sean P.
Daker-White, Gavin
Payne, Katherine
Barton, Anne
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s41927-019-0097-0
- URN
-
urn:nbn:de:101:1-2020030222344390911926
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:58 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Gavan, Sean P.
- Daker-White, Gavin
- Payne, Katherine
- Barton, Anne
- SpringerLink (Online service)
Other Objects (12)
Golimumab: A Novel Anti-Tumor Necrosis Factor
Anti-tumor necrosis factor therapy in inflammatory bowel disease : 15 tables
Update on intravitreal anti-tumor necrosis factor alpha therapies for ocular disorders
Anti-tumor action of tumor necrosis factor against Bomirski Ab melanoma in hamsters
Successful treatment of Cronkhite–Canada syndrome using anti-tumor necrosis factor antibody therapy
Successful treatment with anti-tumor necrosis factor alpha for reactive small-bowel amyloidosis
Anti-tumor necrosis factor patent expiration and the risks of biocopies in clinical practice
Remission of Behcet's disease with anti-tumor necrosis factor monoclonal antibody therapy: a case report
Methotrexate and anti-tumor necrosis factor treatment improves endothelial function in patients with inflammatory arthritis
Decreased influenza-specific B cell responses in rheumatoid arthritis patients treated with anti-tumor necrosis factor
Interactions between rheumatoid arthritis antibodies are associated with the response to anti-tumor necrosis factor therapy
Modulation of T-cell responses by anti-tumor necrosis factor treatments in rheumatoid arthritis: a review
Golimumab: A Novel Anti-Tumor Necrosis Factor
Anti-tumor necrosis factor therapy in inflammatory bowel disease : 15 tables
Update on intravitreal anti-tumor necrosis factor alpha therapies for ocular disorders
Anti-tumor action of tumor necrosis factor against Bomirski Ab melanoma in hamsters
Successful treatment of Cronkhite–Canada syndrome using anti-tumor necrosis factor antibody therapy
Successful treatment with anti-tumor necrosis factor alpha for reactive small-bowel amyloidosis
Anti-tumor necrosis factor patent expiration and the risks of biocopies in clinical practice
Remission of Behcet's disease with anti-tumor necrosis factor monoclonal antibody therapy: a case report
Methotrexate and anti-tumor necrosis factor treatment improves endothelial function in patients with inflammatory arthritis
Decreased influenza-specific B cell responses in rheumatoid arthritis patients treated with anti-tumor necrosis factor
Interactions between rheumatoid arthritis antibodies are associated with the response to anti-tumor necrosis factor therapy
Modulation of T-cell responses by anti-tumor necrosis factor treatments in rheumatoid arthritis: a review
Golimumab: A Novel Anti-Tumor Necrosis Factor
Anti-tumor necrosis factor therapy in inflammatory bowel disease : 15 tables
Update on intravitreal anti-tumor necrosis factor alpha therapies for ocular disorders
Anti-tumor action of tumor necrosis factor against Bomirski Ab melanoma in hamsters
Successful treatment of Cronkhite–Canada syndrome using anti-tumor necrosis factor antibody therapy
Successful treatment with anti-tumor necrosis factor alpha for reactive small-bowel amyloidosis
Anti-tumor necrosis factor patent expiration and the risks of biocopies in clinical practice
Remission of Behcet's disease with anti-tumor necrosis factor monoclonal antibody therapy: a case report
Methotrexate and anti-tumor necrosis factor treatment improves endothelial function in patients with inflammatory arthritis
Decreased influenza-specific B cell responses in rheumatoid arthritis patients treated with anti-tumor necrosis factor
Interactions between rheumatoid arthritis antibodies are associated with the response to anti-tumor necrosis factor therapy